MPAM
LMAT icon

Monarch Partners Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Monarch Partners Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,470
Closed -$264K – 179
2016
Q2 		$264K Buy
18,470
+8,260
+81% +$126K 0.03% 146
2016
Q1 		$158K Buy
+10,210
New +$146K 0.02% 146

Other funds holding LMAT

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monarch Partners Asset Management's LMAT Position: Q3 2016 in Review

Monarch Partners Asset Management sold out of LeMaitre Vascular (LMAT) in Q3 2016, closing a stake of 18,470 shares — an estimated $264K sold.

Monarch Partners Asset Management first reported a position in LMAT in Q1 2016 and held it in 2 quarters. The position peaked at $264K in Q2 2016. 111 funds tracked by Wall St. Rank hold LMAT as of Q3 2016.

  • Monarch Partners Asset Management reported no remaining LeMaitre Vascular position as of Q3 2016 after selling out during the quarter.
  • Monarch Partners Asset Management sold 18,470 LeMaitre Vascular shares in Q3 2016, an estimated $264K.
  • Monarch Partners Asset Management first reported a position in LeMaitre Vascular in Q1 2016 and held it in 2 quarters.
  • Monarch Partners Asset Management's LeMaitre Vascular position peaked at $264K in Q2 2016.
  • 111 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2016.

Based on Monarch Partners Asset Management's 13F filing for Q3 2016, filed 26 Oct 2016.